Stocks and Investing
Stocks and Investing
Tue, November 22, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alexander Nowak Downgraded (BVS) to Hold on, Nov 22nd, 2022
Alexander Nowak of Craig-Hallum, Downgraded "Bioventus Inc." (BVS) to Hold on, Nov 22nd, 2022.
Alexander has made no other calls on BVS in the last 4 months.
There are 4 other peers that have a rating on BVS. Out of the 4 peers that are also analyzing BVS, 2 agree with Alexander's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Wednesday, November 9th, 2022
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $13 on, Wednesday, September 7th, 2022
These are the ratings of the 2 analyists that currently disagree with Alexander
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $5 on, Thursday, November 10th, 2022
- Robbie Marcus of "JP Morgan" Downgraded from Buy to Sell on, Wednesday, November 9th, 2022
Contributing Sources